NZ182165A - Derivatives of 1-(3,5-dihydroxyphenyl)-2 aminoethanol, andpharmaceutical composition - Google Patents

Derivatives of 1-(3,5-dihydroxyphenyl)-2 aminoethanol, andpharmaceutical composition

Info

Publication number
NZ182165A
NZ182165A NZ182165A NZ18216576A NZ182165A NZ 182165 A NZ182165 A NZ 182165A NZ 182165 A NZ182165 A NZ 182165A NZ 18216576 A NZ18216576 A NZ 18216576A NZ 182165 A NZ182165 A NZ 182165A
Authority
NZ
New Zealand
Prior art keywords
andpharmaceutical
aminoethanol
dihydroxyphenyl
derivatives
composition
Prior art date
Application number
NZ182165A
Other languages
English (en)
Inventor
L Sorenby
L Svensson
K Wetterlin
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of NZ182165A publication Critical patent/NZ182165A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NZ182165A 1975-10-01 1976-09-27 Derivatives of 1-(3,5-dihydroxyphenyl)-2 aminoethanol, andpharmaceutical composition NZ182165A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
NZ182165A true NZ182165A (en) 1978-07-10

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ182165A NZ182165A (en) 1975-10-01 1976-09-27 Derivatives of 1-(3,5-dihydroxyphenyl)-2 aminoethanol, andpharmaceutical composition

Country Status (19)

Country Link
JP (1) JPS5242840A (cs)
AT (1) AT347427B (cs)
AU (1) AU503212B2 (cs)
BE (1) BE846837A (cs)
CS (2) CS199643B2 (cs)
DD (1) DD126278A5 (cs)
DE (1) DE2640972A1 (cs)
DK (1) DK141622B (cs)
ES (1) ES451979A1 (cs)
FI (1) FI762660A7 (cs)
FR (1) FR2326183A1 (cs)
GB (1) GB1542317A (cs)
LU (1) LU75916A1 (cs)
NL (1) NL7610845A (cs)
NO (1) NO763345L (cs)
NZ (1) NZ182165A (cs)
SE (1) SE7510988L (cs)
SU (2) SU638252A3 (cs)
ZA (1) ZA765331B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807B1 (en) 1980-07-09 1984-05-30 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
RU2156127C2 (ru) * 1995-12-28 2000-09-20 Еситоми Фармасьютикал Индустриз, Лтд. Препарат местного применения для иммуносупрессии и лечения аутоиммунных или аллергических заболеваний
DK2332921T3 (en) 2003-06-17 2016-05-09 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3benzazepine hydrochloride
SG10201508066VA (en) 2006-04-03 2015-10-29 Arena Pharm Inc Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
WO2008070111A2 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
WO2012030927A2 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-ht2c agonists useful for weight management
CA2808904A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
WO2014058441A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
DK439776A (cs) 1977-04-02
GB1542317A (en) 1979-03-14
NL7610845A (nl) 1977-04-05
AT347427B (de) 1978-12-27
ATA682376A (de) 1978-05-15
BE846837A (fr) 1977-04-01
DD126278A5 (cs) 1977-07-06
DK141622B (da) 1980-05-12
SU674669A3 (ru) 1979-07-15
SE7510988L (sv) 1977-04-02
DE2640972A1 (de) 1977-04-14
FI762660A7 (cs) 1977-04-02
LU75916A1 (cs) 1978-05-16
SU638252A3 (ru) 1978-12-15
ES451979A1 (es) 1978-01-01
AU503212B2 (en) 1979-08-30
NO763345L (cs) 1977-04-04
FR2326183A1 (fr) 1977-04-29
ZA765331B (en) 1977-08-31
CS199644B2 (en) 1980-07-31
AU1812276A (en) 1978-04-06
JPS5242840A (en) 1977-04-04
CS199643B2 (en) 1980-07-31

Similar Documents

Publication Publication Date Title
NZ182165A (en) Derivatives of 1-(3,5-dihydroxyphenyl)-2 aminoethanol, andpharmaceutical composition
IL59829A (en) Derivatives of 9,10-anthracene-bis-carboxaldehyde-bis-hydrazone
PH13173A (en) Derivatives of 5-alkoxy-3-phenyl-1,3,4-oxadiazolin-2-one composition and their method of preparation
SU762760A3 (en) Method of preparing 2,2,6-trimethyl-1-cyclohexene-2-vinylalkanoates
GB1548676A (en) Preparation of 4,4,6-trimethyl-2-cyclohexenone
BG27547A3 (en) Method of obtaining of 1,4- diphenyl- 3- pyrasoline- 5- ones
PL192578A1 (pl) Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow
IL50170A0 (en) Herbicidal compositions containing certain pyridazone-(6)derivatives,their production and their use
IL49160A (en) Preparation of 5-alkyl-1-phenyl-tetrahydro-benz(f)-2,5-oxazocines
NZ182561A (en) Preparation of 2-(3,4-methylenedioxyphenyl)-ethylamine derivatives
HU177938B (en) Herbicide composition containing substituted 2,1,3-benzothiadiazine derivatives and process for preparing 2,1,3-benzothiadiazine derivatives
DK154077A (da) Fremgangsmade til fremstilling og rensning af sekretin
AU509855B2 (en) Compositions of 1, 2, 4-rhiadiazine derivatives
IL50464A0 (en) New 1,2,4-oxadiazin-5-one derivatives their preparation and herbicidal compositions containing them
GB1521089A (en) Aminoethanol derivatives
ZA764890B (en) Production of n,m-diethyl 2 (alpha-naphthoxy) propionamid
ZA762475B (en) Synthesis of 1,2,3,4-tetrahydro-4-oxo-(or-oxo-)-1-naphthylureas
GB1554468A (en) Manufacture of 2,6,6-trimethyl-cyclohex-2 en-1-one
IL49192A (en) 2,3-dihydro-benzofuran-2-one derivatives,their production and pharmalceutical compositions containing them
GB1534024A (en) Derivatives of 1-hydroxy-benzo-2,3,1-diazaborine
GB1551035A (en) Derivatives of bicyclo (2,2,2)oct-3-ylmethylamine
PH13868A (en) Ferrocene derivatives,their pharmaceutical compositions and method of use
PH14669A (en) 1,2-dihydro-6-phenyl-1h,4h-imidazobenzodiazepin-1-one,composition and method of use thereof
AU508662B2 (en) Salts of 1, 3-Bis-(8-Ethylhexyl)-5-Amino-5-Methyl Hexahydropyrinidine
ZA763141B (en) New derivatives of 1-hydroxy-bezno-2,3,1-diazaborine and process for their preparation